Published in:
01-07-2019 | Vestibular Schwannoma | Review Article - Brain Tumors
Radiosurgery treatment is associated with improved facial nerve preservation versus repeat resection in recurrent vestibular schwannomas
Authors:
Prasanth Romiyo, Edwin Ng, Dillon Dejam, Kevin Ding, John P Sheppard, Courtney Duong, Alyssa Franks, Vera Ong, Methma Udawatta, H. Westley Phillips, Quinton Gopen, Isaac Yang
Published in:
Acta Neurochirurgica
|
Issue 7/2019
Login to get access
Abstract
Background
Vestibular schwannomas (VSs) are benign neoplasms of the Schwann cells of cranial nerve VIII, and treatment of VS typically involves surgical resection. However, tumor recurrence may necessitate reintervention, and secondary treatment modalities include repeat surgical resection or adjuvant radiosurgery. The purpose of this study is to examine the scientific literature in order to determine whether surgical resection or radiosurgery for recurrent VS results in better tumor control, hearing preservation, and preservation of facial nerve function.
Methods
The PubMed, Scopus, Embase, Cochrane, and Web of Science databases were searched for studies reporting on patients undergoing either radiosurgery or repeat surgical resection after primary surgical resection for recurrent VS. Statistical analyses were performed on the compiled data, primarily outcome data involving tumor control, hearing preservation, and preservation of facial nerve function.
Results
We analyzed the data of 15 individual studies involving 359 total patients, and our results reveal that tumor control rates are comparable between adjuvant radiosurgery (91%, CI: 88–94%) and secondary resection (92%, CI 75–98%). However, adjuvant radiosurgery was shown to preserve good facial nerve function better (94%, CI 84–98%) compared to secondary surgical resection (56%, CI 41–69%).
Conclusion
With comparable tumor control rates and better preservation of good facial nerve function, this study suggests that secondary radiosurgery for recurrent VS is associated with both optimal tumor control and preservation of good facial nerve function.